Escitalopram (Cipralex® and Lexapro®) for the treatment of depression;Escitalopram (Cipralex®, Lexapro®), behandeling depressie

Geneesmiddelenbulletin

Volumn 38, Issue 12, 2004, Pages 89-90

  Bijl, D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

AGORAPHOBIA; DEPRESSION; DIARRHEA; DRUG EFFECT; EJACULATION DISORDER; HUMAN; NOTE; PANIC; RATING SCALE; SIDE EFFECT; SOCIAL PHOBIA; STATISTICAL SIGNIFICANCE;

EID: 9644303563     PISSN: 03044629     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. IB-teksten Cipramil® en Lexapro® via: www.cbg-meb, Geneesmiddelen-informatiebank.
2. Burke WJ, et al. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002; 63: 331-336.
3. Lepola UM, et al. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primay care. Int Clin Psychopharmacol 2003; 18: 211-217.
4. Montgomery SA, et al. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology 2004; 50: 57-64.
5. Stahl SM, et al. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2003; 64: 1322-1327.
6. Lader M, et al. Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 2004; 19: 241-248.
7. NHG-Standaard Depressieve stoornis. Huisarts Wet 2003; 46: 614-623.
8. NHG-Standaard Angststoornissen (eerste herziening). Huisarts Wet 2004; 47: 26-37.